The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review

Critical Reviews in Food Science and Nutrition

Volumn 56, Issue 8, 2016, Pages 1370-1378

  Charlebois, Ashley ^a   Rosenfeld, Greg ^a   Bressler, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Crohn's disease; diet; exclusion diets; Inflammatory bowel disease; low FODMAP diet; nutrition; ulcerative colitis

Indexed keywords

DISEASES; MEDICAL COMPUTING; PATIENT TREATMENT;

CROHN'S DISEASE; DIETARY MANIPULATION; INFLAMMATORY BOWEL DISEASE; MEDICAL DATABASE; SYSTEMATIC REVIEW; THERAPEUTIC BENEFITS; THREE CATEGORIES; ULCERATIVE COLITIS;

NUTRITION;

ADMINISTRATION AND DOSAGE; CLINICAL TRIAL (TOPIC); CROHN DISEASE; DIET; DIET THERAPY; DIETARY FIBER; FOOD QUALITY; HUMAN; INFLAMMATORY BOWEL DISEASE; MEDLINE; ULCERATIVE COLITIS;

CLINICAL TRIALS AS TOPIC; COLITIS, ULCERATIVE; CROHN DISEASE; DIET; DIETARY FIBER; FOOD QUALITY; HUMANS; INFLAMMATORY BOWEL DISEASES; MEDLINE;

EID: 84975166372     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2012.760515     Document Type: Article

References (43)

1. C.Axelsson, and S.Jarnum, (1977). Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 12:89–95.
2. G.Bartel,, I.Weiss,, K.Turetschek,, W.Schima,, A.Püspök,, T.Waldhoer, and C.Gasche, (2008). Ingested matter affects intestinal lesions in Crohn's disease. Inflamm Bowel Dis. 14:374–382.
3. S.Bentz,, M.Hausmann,, H.Piberger,, S.Kellermeier,, S.Paul,, L.Held,, W.Falk,, F.Obermeier,, M.Fried, and J.Scholmerich,, (2010). Clinical relevance of IgG antibodies against food antigens in Crohn's disease: A double-blind cross-over diet intervention study. Digestion. 81:252–264.
4. S.Björck,, I.Bosaeus,, E.Ek,, E.Jennische,, I.Lönnroth,, E.Johansson, and S.Lange, (2000). Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: A study of a concept. Gut. 46:824–829.
5. O.Borrelli,, L.Cordischi,, M.Cirulli,, M.Paganelli,, V.Labalestra,, S.Uccini,, P.M.Russo, and S.Cucchiara, (2006). Polymeric diet alone versus corticosteroids in the treatment of active pediatric crohn's disease: A randomized controlled open-label trial. Clin. J. Gastroenterol. Hepatol. 4:744–753.
6. R.M.Bostick,, M.Boldt,, M.Darif,, J.R.Wood,, P.Overn, and J.D.Potter, (1997). Calcium and colorectal epithelial cell proliferation in ulcerative colitis. Cancer Epidemiol. Biomark. Prev. 6:1021–1027.
7. S.Candy,, G.Borok,, J.Wright,, V.Boniface, and R.Goodman, (1985). The value of an elimination diet in the management patients with ulcerative colitis. SAMJ. 85:1176–1179.
8. E.Capristo,, G.Mingrone,, G.Addolorato,, A.Greco, and G.Gasbarrini, (2000). Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur. J. Gastroenterol. Hepatol. 12:5–11.
9. F.Casellas,, N.Borruel,, A.Torrejon,, E.Varela,, M.Antolin,, F.Guarner, and J.R.Malagelada, (2007). Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol. Ther. 25:1061–1067.
10. M.Chiba,, T.Abe,, H.Tsuda,, T.Sugawara,, S.Tsuda,, H.Tozawa,, K.Fujiwara, and H.Imai, (2010). Lifestyle-related disease in Crohn's disease: Relapse prevention by a semi-vegetarian diet. World J. Gastroenterol. 16:2484–2495.
11. C.Croagh,, S.J.Shepherd,, M.Berryman,, J.G.Muir, and P.R.Gibson, (2007). Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel. Dis. 13:1522–1528.
12. R.Cunliffe, and B.Scott, (2002). Review article: Monitoring for drug side-effects in inflammatory bowel disease. Aliment Pharmacol. Ther. 16:647–662.
13. M.A.French,, A.M.Parrott,, E.S.Kielo,, R.V.Rajotte,, L.C.Wang,, A.B.Thomson, and M.T.Clandinin, (1997). Polyunsaturated fat in the diet may improve intestinal function in patients with Crohn's disease. Biochimica et Biophysica Acta (BBA)—Mol. Basis Dis. 1360:262–270.
14. R.B.Gearry,, P.M.Irving,, J.S.Barrett,, D.M.Nathan,, S.J.Shepherd, and P.R.Gibson, (2009). Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—a pilot study. J. Crohn's Colitis. 3:8–14.
15. P.R.Gibson, and S.J.Shepherd, (2010). Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J. Gastroenterol. Hepatol. 25:252–258.
16. A.Goode,, J.G.Feggetter,, T.Hawkins, and I.Johnston, (1976). Use of an elemental diet for long-term nutritional support in Crohn's disease. The Lancet. 307:122–124.
17. D.Gorard,, J.Hunt,, J.Payne-James,, K.Palmer,, R.Rees,, M.Clark,, M.J.Farthing,, J.J.Misiewicz, and D.B.Silk, (1993). Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut. 34:1198–1202.
18. T.Grimstad,, R.K.Berge,, P.Bohov,, J.Skorve,, L.Gøransson,, R.Omdal,, O.G.Aasprong,, M.Haugen,, H.M.Meltzer, and T.Hausken, (2011). Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index a pilot study. Scand. J. Clin. Lab Invest. 71:68–73.
19. C.Hallert,, M.Kaldma, and B.G.Petersson, (1991). Ispaghula Husk May Relieve Gastrointestinal Symptoms in Ulcerative Colitis in Remission. Scand. J. Gastroenterol. 26:747–750.
20. K.W.Heaton,, J.R.Thornton,, P.M.Emmett, (1979). Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. BMJ. 2:764–766.
21. S.Imes,, B.Pinchbeck,, A.Dinwoodie,, K.Walker, and A.B.R.Thomson, (1986). Effect of Ensure®, a defined formula diet, in patients with Crohn's disease. Digestion. 35:158–169.
22. V.A.Jones,, E.Workman,, A.H.Freeman,, R.J.Dickinson,, A.J.Wilson, and J.O.Hunter, (1985). Crohn's disease: Maintenance of remission by diet. The Lancet. 326:177–180.
23. O.Kanauchi,, K.Mitsuyama,, T.Homma,, K.Takahama,, Y.Fujiyama,, A.Andoh,, Y.Araki,, T.Suga,, T.Hibi,, M.Naganuma,, (2003). Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial. Int. J. Mol. Med. 12:701–704.
24. O.Kanauchi,, T.Suga,, M.Tochihara,, T.Hibi,, M.Naganuma,, T.Homma,, H.Asakura,, H.Nakano,, K.Takahama,, Y.Fujiyama,, (2002). Treatment of ulcerative colitis by feeding with germinated barley foodstuff: First report of a multicenter open control trial. J. Gastroenterol. 37:S67–S72.
25. P.M.Larsen,, D.Rasmussen,, B.Ronn,, O.Munck,, J.Elmgreen, and V.Binder, (1989). Elemental diet: A therapeutic approach in chronic inflammatory bowel disease. J. Intern. Med. 225:325–331.
26. K.Leiper,, J.Woolner,, M.M.C.Mullan,, T.Parker,, M.van der Vliet,, S.Fear,, J.M.Rhodes, and J.O.Hunter, (2001). A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut. 49:790–794.
27. S.Levenstein,, C.Prantera,, C.Luzi, and A.D’Ubaldi, (1985). Low residue or normal diet in Crohn's disease: A prospective controlled study in Italian patients. Gut. 26:989–993.
28. M.C.E.Lomer,, S.L.Grainger,, R.Ede,, A.P.Catterall,, S.M.Greenfield,, R.E.Cowan,, F.R.Vicary,, A.P.Jenkins,, H.Fidler,, R.S.Harvey,, (2005). Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur. J. Gastroenterol. Hepatol. 17:377–384.
29. H.Malchow,, H.Steinhardt,, H.Lorenz-Meyer,, W.Strohm,, S.Rasmussen,, H.Sommer,, S.Jarnum,, J.W.Brandes,, H.Leonhardt, and K.Ewe, (1990). Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand. J. Gastroenterol. 25:235–244.
30. A.Messori,, G.Trallori,, G.D’albasio,, M.Milla,, G.Vannozzi, and F.Pacini, (1996). Defined-formula diets versus steroids in the treatment of active Crohn's disease a meta-analysis. Scand. J. Gastroenterol. 31:267–272.
31. K.Mitsuyama,, T.Saiki,, O.Kanauchi,, T.Iwanaga,, N.Tomiyasu,, T.Nishiyama,, H.Tateishi,, A.Shirachi,, M.Ide, and A.Suzuki, (1998). Treatment of ulcerative colitis with germinated barley foodstuff feeding: A pilot study. Aliment Pharmacol. Ther. 12:1225–1230.
32. N.A.Molodecky,, I.S.Soon,, D.M.Rabi,, W.A.Ghali,, M.Ferris,, G.Chernoff,, E.I.Benchimol,, R.Panaccione,, S.Gosh,, H.W.Barkema,, (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 142:46–54.
33. C.O’Moráin,, A.W.Segal, and A.J.Levi, (1984). Elemental diet as primary treatment of acute Crohn's disease: A controlled trial. BMJ. 288:1859–1862.
34. N.Rajendran, and D.Kumar, (2010). Role of diet in the management of inflammatory bowel disease. World J. Gastroenterol. 16:1442–1448.
35. N.Rajendran, and D.Kumar, (2011). Food-specific IgG4-guided exclusion diets improve symptoms in Crohn's disease: A pilot study. Colorectal. Disease. 13:1009–1013.
36. A.M.Riordan,, J.O.Hunter,, J.R.Crampton,, G.Neale,, R.E.Cowan,, A.R.Davidson,, R.J.Dickinson,, M.W.Dronfield,, I.W.Fellows,, H.J.Kennedy,, (1993). Treatment of active Crohn's disease by exclusion diet: East Anglian Multicentre Controlled Trial. The Lancet. 342:1131–1134.
37. J.K.Ritchie,, J.Wadsworth,, J.E.Lennard-Jones, and E.Rogers, (1987). Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. BMJ. 295:517–520.
38. B.E.Sands,, J.E.Arsenault,, M.J.Rosen,, M.Alsahli,, L.Bailen,, P.Banks,, S.Bensen,, A.Bousvaros,, D.Cave,, J.S.Cooley,, (2003). Risk of early surgery for Crohn's disease: Implications for early treatment strategies. Am. J. Gastroenterol. 98:2712–2718.
39. S.J.Shepherd,, F.C.Parker,, J.G.Muir, and P.R.Gibson, (2008). Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence. Clin. Gastroenterol. Hepatol. 6:765–771.
40. M.Simren,, J.Axelsson,, R.Gillberg,, H.Abrahamsson,, J.Svedlund, and E.S.Bjornsson, (2002). Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am. J. Gastroenterol. 97:389–396.
41. S.Takagi,, K.Utsunomiya,, S.Kuriyama,, H.Yokoyama,, S.Takahashi,, K.Umemura,, M.Iwabuchi,, H.Takahashi,, S.Takahashi,, Y.Kinouchi,, (2009). Quality of life of patients and medical cost of “half elemental diet” as maintenance therapy for Crohn's disease: Secondary outcomes of a randomised controlled trial. Dig. Liver Dis. 41:390–394.
42. S.S.Teuber, and C.Porch-Curren, (2003). Unproved diagnostic and therapeutic approaches to food allergy and intolerance. Curr. Opin. Allergy Clin. Immunol. 3:217–221.
43. N.L.Zorich,, M.B.Jones,, J.M.Kesler,, S.B.Carter,, M.A.Sutton, and T.Bayless, (1997). A randomized, double-blind study of the effect of olestra on disease activity in patients with quiescent inflammatory bowel disease. Am. J. Med. 103:389–399.